Entering text into the input field will update the search result below

Castle Biosciences EPS beats by $0.35, beats on revenue

Nov. 11, 2019 4:16 PM ETCastle Biosciences, Inc. (CSTL) StockBy: Pranav Ghumatkar, SA News Editor
  • Castle Biosciences (NASDAQ:CSTL): Q3 GAAP EPS of $0.05 beats by $0.35.
  • Revenue of $14.77M (+298.1% Y/Y) beats by $5.32M.
  • Press Release

Recommended For You

More Trending News

About CSTL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CSTL--
Castle Biosciences, Inc.